We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine

Quorum sensing-mediated regulation of staphylococcal virulence and antibiotic resistance

    Rachna Singh,‡

    Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012, India

    Current affiliation: Centre for Microbial Biotechnology, Panjab University, Chandigarh, 160014, India

    Search for more papers by this author

    &
    Pallab Ray

    Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, 160012, India

    Published Online:https://doi.org/10.2217/fmb.14.31

    ABSTRACT: 

    Accessory gene regulator (agr)-mediated quorum sensing plays a central role in staphylococcal pathogenesis. It primarily upregulates secreted virulence factors and downregulates cell surface proteins, thereby governing invasiveness of staphylococci and cell dispersal from biofilms. Except for α- and β-PSMs, which are directly controlled by AgrA, the effector functions of agr are primarily mediated by RNAIII, a regulatory RNA encoded by this operon. agr phenotype and expression considerably influence the chronicity of an infection. It has also been linked with altered susceptibility of Staphylococcus aureus against antibiotics. Four classes of S. aureus and Staphylococcus epidermidis AIPs exist based on sequence variation, and lead to inter-strain and species cross-inhibition. Certain agr classes have been associated with specific clonal complexes, disease syndromes and intermediate-susceptibility to glycopeptides. It is also being investigated as a prophylactic and therapeutic target. This article describes the presently available literature regarding the role of agr in S. aureus and S. epidermidis infections.

    Papers of special note have been highlighted as: • of interest; •• of considerable interest

    References

    • 1 Waters CM, Bassler BL. Quorum sensing: cell-to-cell communication in bacteria. Annu. Rev. Cell. Dev. Biol. 21, 319–346 (2005).
    • 2 Hogan DA. Talking to themselves: autoregulation and quorum sensing in fungi. Eukaryot. Cell. 5(4), 613–619 (2006).
    • 3 Garmyn D, Gal L, Lemaitre JP, Hartmann A, Piveteau P. Communication and autoinduction in the species Listeria monocytogenes: a central role for the agr system. Commun. Integr. Biol. 2(4), 371–374 (2009).
    • 4 Zhang LH, Dong YH. Quorum sensing and signal interference: diverse implications. Mol. Microbiol. 53(6), 1563–1571 (2004).
    • 5 Nealson KH, Platt T, Hastings JW. Cellular control of the synthesis and activity of the bacterial luminescent system. J. Bacteriol. 104(1), 313–322 (1970).
    • 6 Yarwood JM, Schlievert PM. Quorum sensing in Staphylococcus infections. J. Clin. Invest. 112(11), 1620–1625 (2003). •• Important review detailing quorum sensing in staphylococci, including the molecular mechanisms of its activation and its role in regulating the expression of virulence factors.
    • 7 Ray P, Gautam V, Singh R. Methicillin-resistant Staphylococcus aureus (MRSA) in developing and developed countries: implications and solutions. Regional Health Forum (WHO South-East Asia Region), Special Issue on Antimicrobial Resistance in South-East Asia 15(1), 74–82 (2011).
    • 8 Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat. Rev. Microbiol. 2(2), 95–108 (2004).
    • 9 Hall-Stoodley L, Stoodley P. Evolving concepts in biofilm infections. Cell. Microbiol. 11(7), 1034–1043 (2009).
    • 10 Otto M. Staphylococcus epidermidis – the ’accidental’ pathogen. Nat. Rev. Microbiol. 7(8), 555–567 (2009).
    • 11 O’Gara JP, Humphreys H. Staphylococcus epidermidis biofilms: importance and implications. J. Med. Microbiol. 50(7), 582–587 (2001).
    • 12 Mack D, Davies AP, Harris LG, Rohde H, Horstkotte MA, Knobloch JK. Microbial interactions in Staphylococcus epidermidis biofilms. Anal. Bioanal. Chem. 387(2), 399–408 (2007). • Comprehensive review describing biofilm formation in Staphylococcus epidermidis, with emphasis on the role of quorum sensing.
    • 13 Archer NK, Mazaitis MJ, Costerton JW, Leid JG, Powers ME, Shirtliff ME. Staphylococcus aureus biofilms: properties, regulation, and roles in human disease. Virulence 2(5), 445–459 (2011).  • Describes the recent developments related to biofilm formation in Staphylococcus aureus, including the contribution of quorum sensing.
    • 14 Cameron DR, Howden BP, Peleg AY. The interface between antibiotic resistance and virulence in Staphylococcus aureus and its impact upon clinical outcomes. Clin. Infect. Dis. 53(6), 576–582 (2011).
    • 15 Considine KM, Sleator RD, Kelly AL, Fitzgerald GF, Hill C. Novel listerial genetic loci conferring enhanced barotolerance in Escherichia coli. J. Appl. Microbiol. 110(3), 618–630 (2011).
    • 16 Novick RP, Projan SJ, Kornblum J et al. The agr P2 operon: an autocatalytic sensory transduction system in Staphylococcus aureus. Mol. Gen. Genet. 248(4), 446–458 (1995). •• One of the pioneering publications describing the agr quorum-sensing system in S. aureus.
    • 17 Novick RP, Ross HF, Projan SJ, Kornblum J, Kreiswirth B, Moghazeh S. Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule. EMBO J. 12(10), 3967–3975 (1993). •• One of the seminal publications reporting that RNAIII mediates the effector functions of agr.
    • 18 Ji G, Beavis RC, Novick RP. Cell density control of staphylococcal virulence mediated by an octapeptide pheromone. Proc. Natl Acad. Sci. USA 92(26), 12055–12059 (1995). •• One of the pioneering publications describing the agr quorum-sensing system in S. aureus.
    • 19 Regassa LB, Novick RP, Betley MJ. Glucose and nonmaintained pH decrease expression of the accessory gene regulator (agr) in Staphylococcus aureus. Infect. Immun. 60(8), 3381–3388 (1992).
    • 20 Oun S, Redder P, Didier JP et al. The CshA DEAD-box RNA helicase is important for quorum sensing control in Staphylococcus aureus. RNA Biol. 10(1), 157–165 (2013).
    • 21 Balaban N, Goldkorn T, Gov Y et al. Regulation of Staphylococcus aureus pathogenesis via target of RNAIII-activating protein (TRAP). J. Biol. Chem. 276(4), 2658–2667 (2001).
    • 22 Bronner S, Monteil H, Prevost G. Regulation of virulence determinants in Staphylococcus aureus: complexity and applications. FEMS Microbiol. Rev. 28(2), 183–200 (2004). • Exhaustive review on virulence regulators in S. aureus, including agr.
    • 23 Gov Y, Borovok I, Korem M et al. Quorum sensing in Staphylococci is regulated via phosphorylation of three conserved histidine residues. J. Biol. Chem. 279(15), 14665–14672 (2004).
    • 24 Korem M, Sheoran AS, Gov Y, Tzipori S, Borovok I, Balaban N. Characterization of RAP, a quorum sensing activator of Staphylococcus aureus. FEMS Microbiol. Lett. 223(2), 167–175 (2003).
    • 25 Balaban N, Goldkorn T, Nhan RT et al. Autoinducer of virulence as a target for vaccine and therapy against Staphylococcus aureus. Science 280(5362), 438–440 (1998). •• Describes the identification and charcterization of RAP as a regulator of agr and a target for antistaphylococcal prophylaxis and therapy.
    • 26 Novick RP, Ross HF, Figueiredo AMS, Abramochkin G, Muir T. Technical comment: activation and inhibition of the staphylococcal AGR system. Science 287(5452), 391 (2000). •• Opposes the viewpoint of Balaban et al. [25] regarding agr activation by RAP via TRAP.
    • 27 Adhikari RP, Arvidson S, Novick RP. A nonsense mutation in agrA accounts for the defect in agr expression and the avirulence of Staphylococcus aureus 8325–8324 traP::kan. Infect. Immun. 75(9), 4534–4540 (2007).
    • 28 Kiran MD, Balaban N. TRAP plays a role in stress response in Staphylococcus aureus. Int. J. Artif. Organs 32(9), 592–599 (2009). •• A recent study indicating that TRAP does not regulate agr; instead, it protects DNA from oxidative damage, and thereby spontaneous and adaptive mutations including those of agr.
    • 29 Chen J, Novick RP. svrA, a multi-drug exporter, does not control agr. Microbiology 153(Pt 5), 1604–1608 (2007).
    • 30 Tegmark K, Morfeldt E, Arvidson S. Regulation of agr-dependent virulence genes in Staphylococcus aureus by RNAIII from coagulase-negative staphylococci. J. Bacteriol. 180(12), 3181–3186 (1998).
    • 31 Van Wamel WJ, Van Rossum G, Verhoef J, Vandenbroucke-Grauls CM, Fluit AC. Cloning and characterization of an accessory gene regulator (agr)-like locus from Staphylococcus epidermidis. FEMS Microbiol. Lett. 163(1), 1–9 (1998).
    • 32 Dufour P, Jarraud S, Vandenesch F et al. High genetic variability of the agr locus in Staphylococcus species. J. Bacteriol. 184(4), 1180–1186 (2002).
    • 33 Jarraud S, Lyon GJ, Figueiredo AM et al. Exfoliatin-producing strains define a fourth agr specificity group in Staphylococcus aureus. J. Bacteriol. 182(22), 6517–6522 (2000).
    • 34 Ji G, Beavis R, Novick RP. Bacterial interference caused by autoinducing peptide variants. Science 276(5321), 2027–2030 (1997).
    • 35 Wright JS 3rd, Traber KE, Corrigan R, Benson SA, Musser JM, Novick RP. The agr radiation: an early event in the evolution of staphylococci. J. Bacteriol. 187(16), 5585–5594 (2005).
    • 36 Otto M, Echner H, Voelter W, Gotz F. Pheromone cross-inhibition between Staphylococcus aureus and Staphylococcus epidermidis. Infect. Immun. 69(3), 1957–1960 (2001).
    • 37 Dassy B, Hogan T, Foster TJ, Fournier JM. Involvement of the accessory gene regulator (agr) in expression of type 5 capsular polysaccharide by Staphylococcus aureus. J. Gen. Microbiol. 139 Pt 6, 1301–1306 (1993).
    • 38 Luong T, Sau S, Gomez M, Lee JC, Lee CY. Regulation of Staphylococcus aureus capsular polysaccharide expression by agr and sarA. Infect. Immun. 70(2), 444–450 (2002).
    • 39 Van Wamel W, Xiong YQ, Bayer AS, Yeaman MR, Nast CC, Cheung AL. Regulation of Staphylococcus aureus type 5 capsular polysaccharides by agr and sarA in vitro and in an experimental endocarditis model. Microb. Pathog. 33(2), 73–79 (2002).
    • 40 Vuong C, Gotz F, Otto M. Construction and characterization of an agr deletion mutant of Staphylococcus epidermidis. Infect. Immun. 68(3), 1048–1053 (2000).
    • 41 Batzilla CF, Rachid S, Engelmann S, Hecker M, Hacker J, Ziebuhr W. Impact of the accessory gene regulatory system (Agr) on extracellular proteins, codY expression and amino acid metabolism in Staphylococcus epidermidis. Proteomics 6(12), 3602–3613 (2006).
    • 42 Vuong C, Durr M, Carmody AB, Peschel A, Klebanoff SJ, Otto M. Regulated expression of pathogen-associated molecular pattern molecules in Staphylococcus epidermidis: quorum-sensing determines pro-inflammatory capacity and production of phenol-soluble modulins. Cell. Microbiol. 6(8), 753–759 (2004).
    • 43 Recsei P, Kreiswirth B, O’Reilly M, Schlievert P, Gruss A, Novick RP. Regulation of exoprotein gene expression in Staphylococcus aureus by agr. Mol. Gen. Genet. 202(1), 58–61 (1986).
    • 44 Saravia-Otten P, Muller HP, Arvidson S. Transcription of Staphylococcus aureus fibronectin binding protein genes is negatively regulated by agr and an agr-independent mechanism. J. Bacteriol. 179(17), 5259–5263 (1997).
    • 45 Beenken KE, Dunman PM, Mcaleese F et al. Global gene expression in Staphylococcus aureus biofilms. J. Bacteriol. 186(14), 4665–4684 (2004).
    • 46 Dunman PM, Murphy E, Haney S et al. Transcription profiling-based identification of Staphylococcus aureus genes regulated by the agr and/or sarA loci. J. Bacteriol. 183(24), 7341–7353 (2001).
    • 47 Felden B, Vandenesch F, Bouloc P, Romby P. The Staphylococcus aureus RNome and its commitment to virulence. PLoS Pathog. 7(3), e1002006 (2011). • Exhaustive review describing the molecular mechanisms involved in RNAIII-mediated regulation of staphylococcal virulence factors.
    • 48 Peschel A, Otto M. Phenol-soluble modulins and staphylococcal infection. Nat. Rev. Microbiol. 11(10), 667–673 (2013).
    • 49 Queck SY, Jameson-Lee M, Villaruz AE et al. RNAIII-independent target gene control by the agr quorum-sensing system: insight into the evolution of virulence regulation in Staphylococcus aureus. Mol. Cell. 32(1), 150–158 (2008). •• An important article describing the direct regulation of α- and β-phenol soluble modulins by AgrA, in a RNAIII-independent manner.
    • 50 Park SY, Chong YP, Park HJ et al. agr dysfunction and persistent methicillin-resistant Staphylococcus aureus bacteremia in patients with removed eradicable foci. Infection 41(1), 111–119 (2013).
    • 51 Paulander W, Nissen Varming A, Baek KT, Haaber J, Frees D, Ingmer H. Antibiotic-mediated selection of quorum-sensing-negative Staphylococcus aureus. MBio 3(6), e00459–00412 (2013).
    • 52 Smyth DS, Kafer JM, Wasserman GA et al. Nasal carriage as a source of agr-defective Staphylococcus aureus bacteremia. J. Infect. Dis. 206(8), 1168–1177 (2012).
    • 53 Harding MW, Marques LL, Howard RJ, Olson ME. Can filamentous fungi form biofilms? Trends Microbiol. 17(11), 475–480 (2009).
    • 54 Boles BR, Horswill AR. Agr-mediated dispersal of Staphylococcus aureus biofilms. PLoS Pathog. 4(4), e1000052 (2008). • Reports the mechanisms by which agr regulates staphylococcal biofilm development.
    • 55 Pratten J, Foster SJ, Chan PF, Wilson M, Nair SP. Staphylococcus aureus accessory regulators: expression within biofilms and effect on adhesion. Microbes Infect. 3(8), 633–637 (2001).
    • 56 Shenkman B, Varon D, Tamarin I et al. Role of agr (RNAIII) in Staphylococcus aureus adherence to fibrinogen, fibronectin, platelets and endothelial cells under static and flow conditions. J. Med. Microbiol. 51(9), 747–754 (2002).
    • 57 Vuong C, Gerke C, Somerville GA, Fischer ER, Otto M. Quorum-sensing control of biofilm factors in Staphylococcus epidermidis. J. Infect. Dis. 188(5), 706–718 (2003).
    • 58 Vuong C, Kocianova S, Yao Y, Carmody AB, Otto M. Increased colonization of indwelling medical devices by quorum-sensing mutants of Staphylococcus epidermidis in vivo. J. Infect. Dis. 190(8), 1498–1505 (2004).
    • 59 Vuong C, Saenz HL, Gotz F, Otto M. Impact of the agr quorum-sensing system on adherence to polystyrene in Staphylococcus aureus. J. Infect. Dis. 182(6), 1688–1693 (2000).
    • 60 Yarwood JM, Bartels DJ, Volper EM, Greenberg EP. Quorum sensing in Staphylococcus aureus biofilms. J. Bacteriol. 186(6), 1838–1850 (2004).
    • 61 Yarwood JM, Paquette KM, Tikh IB, Volper EM, Greenberg EP. Generation of virulence factor variants in Staphylococcus aureus biofilms. J. Bacteriol. 189(22), 7961–7967 (2007).
    • 62 Periasamy S, Joo HS, Duong AC et al. How Staphylococcus aureus biofilms develop their characteristic structure. Proc. Natl Acad. Sci. USA 109(4), 1281–1286 (2012).
    • 63 Ferreira FA, Souza RR, De Sousa Moraes B et al. Impact of agr dysfunction on virulence profiles and infections associated with a novel methicillin-resistant Staphylococcus aureus (MRSA) variant of the lineage ST1-SCCmec IV. BMC Microbiol. 13, 93 (2013).
    • 64 Dai L, Yang L, Parsons C, Findlay VJ, Molin S, Qin Z. Staphylococcus epidermidis recovered from indwelling catheters exhibit enhanced biofilm dispersal and 'self-renewal' through downregulation of agr. BMC Microbiol. 12, 102 (2012).
    • 65 Savage VJ, Chopra I, O’Neill AJ. Population diversification in Staphylococcus aureus biofilms may promote dissemination and persistence. PLoS ONE 8(4), e62513 (2013).
    • 66 Wang R, Khan BA, Cheung GY et al. Staphylococcus epidermidis surfactant peptides promote biofilm maturation and dissemination of biofilm-associated infection in mice. J. Clin. Invest. 121(1), 238–248 (2011).
    • 67 Xu L, Li H, Vuong C et al. Role of the luxS quorum-sensing system in biofilm formation and virulence of Staphylococcus epidermidis. Infect. Immun. 74(1), 488–496 (2006).
    • 68 Yu D, Zhao L, Xue T, Sun B. Staphylococcus aureus autoinducer-2 quorum sensing decreases biofilm formation in an icaR-dependent manner. BMC Microbiol. 12, 288 (2012).
    • 69 Cafiso V, Bertuccio T, Santagati M et al. agr-Genotyping and transcriptional analysis of biofilm-producing Staphylococcus aureus. FEMS Immunol. Med. Microbiol. 51(1), 220–227 (2007).
    • 70 Park C, Shin NY, Byun JH et al. Downregulation of RNAIII in vancomycin-intermediate Staphylococcus aureus strains regardless of the presence of agr mutation. J. Med. Microbiol. 61(Pt 3), 345–352 (2011).
    • 71 Horne KC, Howden BP, Grabsch EA et al. Prospective comparison of the clinical impacts of heterogeneous vancomycin-intermediate methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-susceptible MRSA. Antimicrob. Agents Chemother. 53(8), 3447–3452 (2009).
    • 72 Fujimoto DF, Bayles KW. Opposing roles of the Staphylococcus aureus virulence regulators, agr and sar, in Triton X-100- and penicillin-induced autolysis. J. Bacteriol. 180(14), 3724–3726 (1998).
    • 73 Sakoulas G, Eliopoulos GM, Fowler VG Jr et al. Reduced susceptibility of Staphylococcus aureus to vancomycin and platelet microbicidal protein correlates with defective autolysis and loss of accessory gene regulator (agr) function. Antimicrob. Agents Chemother. 49(7), 2687–2692 (2005). •• Describes a correlation between the development of VISA, loss of agr function and defective autolysis.
    • 74 Sakoulas G, Eliopoulos GM, Moellering RC Jr et al. Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin. Antimicrob. Agents Chemother. 46(5), 1492–1502 (2002).
    • 75 Viedma E, Sanz F, Orellana MA et al. Relationship between agr dysfunction and reduced vancomycin susceptibility in methicillin-susceptible Staphylococcus aureus causing bacteraemia. J. Antimicrob. Chemother. 69(1), 51–58 (2013).
    • 76 De Sanctis JT, Swami A, Sawarynski K et al. Is there a clinical association of vancomycin MIC creep, agr group II locus, and treatment failure in MRSA bacteremia? Diagn. Mol. Pathol. 20(3), 184–188 (2011).
    • 77 Tsuji BT, Rybak MJ, Lau KL, Sakoulas G. Evaluation of accessory gene regulator (agr) group and function in the proclivity towards vancomycin intermediate resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 51(3), 1089–1091 (2007).
    • 78 Singh R, Ray P, Das A, Sharma M. Role of persisters and small-colony variants in antibiotic resistance of planktonic and biofilm-associated Staphylococcus aureus: an in vitro study. J. Med. Microbiol. 58(Pt 8), 1067–1073 (2009).
    • 79 Singh R, Ray P. Comment on: densely adherent growth mode, rather than extracellular polymer substance matrix build-up ability, contributes to high resistance of Staphylococcus epidermidis biofilms to antibiotics. J. Antimicrob. Chemother. 65(9), 2054–2055; author reply 2055–2056 (2010).
    • 80 Singh R, Ray P, Das A, Sharma M. Penetration of antibiotics through Staphylococcus aureus and Staphylococcus epidermidis biofilms. J. Antimicrob. Chemother. 65(9), 1955–1958 (2010).
    • 81 Singh R, Ray P, Das A, Sharma M. MRT letter: Spatial distribution of vancomycin-induced damage in Staphylococcus epidermidis biofilm: an electron microscopic study. Microsc. Res. Tech. 73(7), 662–664 (2010).
    • 82 Singh R, Ray P, Das A, Sharma M. Enhanced production of exopolysaccharide matrix and biofilm by a menadione-auxotrophic Staphylococcus aureus small-colony variant. J. Med. Microbiol. 59(Pt 5), 521–527 (2010).
    • 83 Singh R, Ray P. Vancomycin modulated autolysis in Staphylococcus aureus: does it vary with the susceptibility and planktonic or biofilm phenotype? FEMS Immunol. Med. Microbiol. 65(1), 1–4 (2012).
    • 84 Park HJ, Moon YH, Yoon HE, Park YM, Yoon JH, Bang IS. Agr function is upregulated by photodynamic therapy for Staphylococcus aureus and is related to resistance to photodynamic therapy. Microbiol. Immunol. 57(8), 547–552 (2013).
    • 85 Jarraud S, Mougel C, Thioulouse J et al. Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Infect. Immun. 70(2), 631–641 (2002). •• Describes the association of specific agr classes with distinct clinical syndromes caused by S. aureus.
    • 86 Bhatty M, Ray P, Singh R, Jain S, Sharma M. Presence of virulence determinants amongst Staphylococcus aureus isolates from nasal colonization, superficial & invasive infections. Indian J. Med. Res. 138(1), 143–146 (2013).
    • 87 Hellmark B, Soderquist B, Unemo M, Nilsdotter-Augustinsson A. Comparison of Staphylococcus epidermidis isolated from prosthetic joint infections and commensal isolates in regard to antibiotic susceptibility, agr type, biofilm production, and epidemiology. Int. J. Med. Microbiol. 303(1), 32–39 (2013).
    • 88 Holtfreter S, Grumann D, Schmudde M et al. Clonal distribution of superantigen genes in clinical Staphylococcus aureus isolates. J. Clin. Microbiol. 45(8), 2669–2680 (2007).
    • 89 Lindsay JA, Moore CE, Day NP et al. Microarrays reveal that each of the ten dominant lineages of Staphylococcus aureus has a unique combination of surface-associated and regulatory genes. J. Bacteriol. 188(2), 669–676 (2006).
    • 90 Peacock SJ, Moore CE, Justice A et al. Virulent combinations of adhesin and toxin genes in natural populations of Staphylococcus aureus. Infect. Immun. 70(9), 4987–4996 (2002).
    • 91 Monk AB, Curtis S, Paul J, Enright MC. Genetic analysis of Staphylococcus aureus from intravenous drug user lesions. J. Med. Microbiol. 53(Pt 3), 223–227 (2004).
    • 92 Kiedrowski MR, Horswill AR. New approaches for treating staphylococcal biofilm infections. Ann. NY Acad. Sci. 1241(1), 104–121 (2011).
    • 93 Leitner G, Krifucks O, Kiran MD, Balaban N. Vaccine development for the prevention of staphylococcal mastitis in dairy cows. Vet. Immunol. Immunopathol. 142(1–2), 25–35 (2011).
    • 94 Yang G, Gao Y, Dong J et al. A novel peptide screened by phage display can mimic TRAP antigen epitope against Staphylococcus aureus infections. J. Biol. Chem. 280(29), 27431–27435 (2005).
    • 95 Yang G, Gao Y, Dong J et al. A novel peptide isolated from phage library to substitute a complex system for a vaccine against staphylococci infection. Vaccine 24(8), 1117–1123 (2006).
    • 96 Henrick K, Hirshberg M. Structure of the signal transduction protein TRAP (target of RNAIII-activating protein). Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 68(Pt 7), 744–750 (2012).
    • 97 Anguita-Alonso P, Giacometti A, Cirioni O et al. RNAIII-inhibiting-peptide-loaded polymethylmethacrylate prevents in vivo Staphylococcus aureus biofilm formation. Antimicrob. Agents Chemother. 51(7), 2594–2596 (2007).
    • 98 Lopez-Leban F, Kiran MD, Wolcott R, Balaban N. Molecular mechanisms of RIP, an effective inhibitor of chronic infections. Int. J. Artif. Organs 33(9), 582–589 (2010).
    • 99 Schierle CF, De La Garza M, Mustoe TA, Galiano RD. Staphylococcal biofilms impair wound healing by delaying reepithelialization in a murine cutaneous wound model. Wound Repair Regen. 17(3), 354–359 (2009).
    • 100 Otto M. Quorum-sensing control in Staphylococci – a target for antimicrobial drug therapy? FEMS Microbiol. Lett. 241(2), 135–141 (2004).
    • 101 Shaw LN, Jonsson IM, Singh VK, Tarkowski A, Stewart GC. Inactivation of traP has no effect on the agr quorum-sensing system or virulence of Staphylococcus aureus. Infect. Immun. 75(9), 4519–4527 (2007).
    • 102 Kiran MD, Adikesavan NV, Cirioni O et al. Discovery of a quorum-sensing inhibitor of drug-resistant staphylococcal infections by structure-based virtual screening. Mol. Pharmacol. 73(5), 1578–1586 (2008).
    • 103 Schweizer ML, Furuno JP, Sakoulas G et al. Increased mortality with accessory gene regulator (agr) dysfunction in Staphylococcus aureus among bacteremic patients. Antimicrob. Agents Chemother. 55(3), 1082–1087 (2011).
    • 104 Benito Y, Kolb FA, Romby P, Lina G, Etienne J, Vandenesch F. Probing the structure of RNAIII, the Staphylococcus aureus agr regulatory RNA, and identification of the RNA domain involved in repression of protein A expression. RNA 6(5), 668–679 (2000).